Dirk Deleu Selected Research

Central Pontine Myelinolysis

1/2012	Extrapontine myelinolysis-induced parkinsonism in a patient with adrenal crisis.
10/2005	"Man-in-the-barrel" syndrome as delayed manifestation of extrapontine and central pontine myelinolysis: beneficial effect of intravenous immunoglobulin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dirk Deleu Research Topics

Disease

12	Stroke (Strokes) 12/2020 - 08/2015
10	Multiple Sclerosis 12/2021 - 06/2007
7	Atrial Fibrillation 12/2020 - 08/2015
6	Infections 12/2021 - 08/2005
5	Hemorrhage 12/2020 - 08/2015
4	Epilepsy (Aura) 01/2021 - 12/2003
4	Parkinson Disease (Parkinson's Disease) 01/2004 - 01/2002
3	Ischemic Stroke 12/2020 - 11/2018
3	Seizures (Absence Seizure) 01/2019 - 09/2006
3	Hemifacial Spasm 10/2005 - 06/2004
2	Cranial Nerve Diseases (Cranial Nerve Disorders) 01/2022 - 01/2015
2	Infarction (Infarctions) 01/2022 - 02/2010
2	COVID-19 12/2021 - 06/2021
2	Relapsing-Remitting Multiple Sclerosis 01/2019 - 01/2017
2	Embolic Stroke 01/2019 - 08/2015
2	Central Pontine Myelinolysis 01/2012 - 10/2005
2	Status Epilepticus (Complex Partial Status Epilepticus) 12/2003 - 01/2002
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2022
1	Granuloma 01/2022
1	Hydrocephalus (Hydrocephaly) 01/2022
1	Urinary Tract Infections (Urinary Tract Infection) 01/2021
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2021
1	Bacterial Meningitis 09/2020
1	Arterial Occlusive Diseases (Arterial Occlusive Disease) 01/2020
1	Temporal Lobe Epilepsy 01/2020
1	Drug Resistant Epilepsy 01/2019
1	Brain Diseases (Brain Disorder) 01/2019
1	Leukoaraiosis 01/2019
1	Nerve Degeneration 01/2017
1	Coma (Comas) 01/2017
1	Spontaneous Abortion (Miscarriage) 01/2016
1	Aphasia (Dysphasia) 01/2015
1	Neck Pain (Cervicalgia) 01/2015
1	Paresis (Hemiparesis) 01/2015
1	Poisoning 08/2014
1	Neurologic Manifestations (Neurological Manifestations) 08/2014
1	Ophthalmoplegia (External Ophthalmoplegia) 01/2013
1	Hyponatremia 01/2012
1	Wounds and Injuries (Trauma) 01/2012
1	Opsoclonus-Myoclonus Syndrome (Kinsbourne Syndrome) 06/2011
1	Mycoplasma Pneumonia 06/2011
1	Chronic Disease (Chronic Diseases) 04/2010
1	Disease Progression 10/2008
1	Partial Epilepsies (Epilepsy, Partial) 09/2007
1	Joint Diseases (Joint Disease) 06/2007
1	Demyelinating Diseases (Demyelinating Disease) 06/2007
1	Necrosis 06/2007
1	Optic Atrophy 06/2007

Drug/Important Bio-Agent (IBA)

7	AnticoagulantsIBA 12/2020 - 08/2015
4	Fingolimod Hydrochloride (FTY720)FDA Link 12/2021 - 06/2019
3	InterferonsIBA 12/2021 - 01/2016
3	Natalizumab (Tysabri)FDA Link 12/2021 - 06/2019
3	Alemtuzumab (Campath)FDA Link 12/2021 - 06/2019
3	Cladribine FDA LinkGeneric 12/2021 - 06/2019
3	TabletsIBA 12/2021 - 06/2019
3	Dopamine Agonists (Dopamine Agonist)IBA 01/2004 - 10/2002
2	teriflunomideIBA 12/2021 - 06/2021
2	Dimethyl FumarateIBA 12/2021 - 06/2021
2	Glatiramer Acetate (Copaxone)FDA Link 12/2021 - 06/2021
2	ocrelizumabIBA 01/2021 - 06/2019
2	Vitamin K FDA Link 01/2020 - 01/2019
2	Pharmaceutical PreparationsIBA 01/2020 - 12/2003
2	Intravenous Immunoglobulins (IVIG)FDA Link 01/2013 - 10/2005
2	SteroidsIBA 01/2012 - 08/2005
2	Levodopa (L Dopa)FDA LinkGeneric 10/2008 - 01/2004
2	Botulinum Toxins (Botulinum Toxin)IBA 10/2005 - 10/2005
2	Phenytoin (Dilantin)FDA LinkGeneric 12/2003 - 01/2002
1	insulin receptor-related receptor (IRR)IBA 01/2021
1	tyramine-deoxysorbitolIBA 09/2020
1	Rituximab (Mabthera)FDA Link 01/2020
1	Cytidine Triphosphate (CTP)IBA 01/2020
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2019
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2019
1	DNA (Deoxyribonucleic Acid)IBA 01/2019
1	Anticonvulsants (Antiepileptic Drugs)IBA 01/2019
1	Retinaldehyde (Retinal)IBA 01/2017
1	C-Reactive ProteinIBA 01/2015
1	SolventsIBA 08/2014
1	diethylene glycolIBA 08/2014
1	Immunoglobulin G (IgG)IBA 01/2013
1	Blood Glucose (Blood Sugar)IBA 01/2012
1	Capsules (Microcapsules)IBA 02/2010
1	Valproic Acid (Depakote)FDA LinkGeneric 09/2007
1	Delayed-Action PreparationsIBA 09/2007
1	Etanercept (Enbrel)FDA Link 06/2007
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2007
1	factor V LeidenIBA 11/2006
1	Protein CIBA 11/2006
1	Prothrombin (Factor II)IBA 11/2006
1	Antithrombin IIIIBA 11/2006

Therapy/Procedure

21	Therapeutics 12/2021 - 01/2002
5	Length of Stay 01/2017 - 12/2015
2	Secondary Prevention 01/2020 - 02/2016
1	Ventriculoperitoneal Shunt 01/2022
1	Complementary Therapies (Alternative Medicine) 01/2021
1	Thrombolytic Therapy 01/2020
1	Thrombectomy 01/2020
1	Precision Medicine 01/2019
1	Chiropractic Manipulation 01/2015
1	Plasmapheresis 06/2011